CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 88 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2017. The put-call ratio across all filers is 18.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $363,000 | +188.1% | 290,532 | +314.9% | 0.00% | +50.0% |
| Q3 2020 | $126,000 | -89.7% | 70,026 | -51.8% | 0.00% | -90.0% |
| Q2 2020 | $1,218,000 | +859.1% | 145,140 | +455.1% | 0.02% | +1900.0% |
| Q3 2019 | $127,000 | -13.6% | 26,148 | +8.4% | 0.00% | -50.0% |
| Q1 2018 | $147,000 | -33.5% | 24,126 | -22.5% | 0.00% | -50.0% |
| Q4 2017 | $221,000 | +234.8% | 31,127 | +197.0% | 0.00% | +300.0% |
| Q2 2017 | $66,000 | – | 10,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |